Načítá se...
Use of novel oral anticoagulant agents in atrial fibrillation: current evidence and future perspective
The increasing availability of novel oral anticoagulants (NOAC) for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF) offers alternatives for patients currently prescribed warfarin. This article provides a brief overview on the mechanism and clinica...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4147091/ https://ncbi.nlm.nih.gov/pubmed/25276617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2223-3652.2014.08.01 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|